Boston, Massachusetts, Sept. 26, 2024 (GLOBE NEWSWIRE) — Teledyne DALSA, ein Unternehmen von Teledyne Technologies [NYSE:TDY] und weltweit führend in […]
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3 Evaxion will host a conference […]
MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company […]